Our regular coverage of developments in the field of surgical sealants, hemostasis, wound closure and anti-adhesion, most recently through Report #S180, entails the full potential caseload of patients targeted by these technologies and therefore necessarily encompasses more traditional wound closure methods, such as sutures, staples and clips.
Our regular coverage of developments in the field of surgical sealants, hemostasis, wound closure and anti-adhesion, most recently through Report #S180, entails the full potential caseload of patients targeted by these technologies and therefore necessarily encompasses more traditional wound closure methods, such as sutures, staples and clips.
There is considerable revenue from the sale of these products that is the focus of well established medtech companies. While sealants, glues, hemostats and other non-traditional wound management products are the thrust of aggressive development by many companies, their ultimate target is largely the market served by traditional wound closure products.
Below is illustrated the number of active companies participating in each of the traditional types of traditional wound closure product segments.
Source: MedMarket Diligence, LLC; Report #S180.
To consider this another way, there are a good number of active companies in these traditional areas, with some predictable ones active in multiple segments. See this below.
Source: MedMarket Diligence, LLC; Report #S180.
